ArticleMolecular cancer2011

Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.

Jianjun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.